A Clinical Trial of GSK3640254 + Dolutegravir (DTG) in Human Immunodeficiency Virus-1 Infected Treatment-naive Adults
Clinical trial NCT04900038 · TERMINATED
Trial details
- NCT number
- NCT04900038
- Sponsor
- ViiV Healthcare
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-18
- Primary completion
- 2022-11-22
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.